Houston Methodist's Center for RNA Therapeutics, led by John Cooke, is an academic mRNA vaccine programme with cancer studies opening for enrolment.
The Center for RNA Therapeutics at Houston Methodist Academic Institute develops mRNA-based therapies and vaccines, including cancer vaccines, under John Cooke; Future of Cancer Care Today lists it for trial enrolment as studies open.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Houston Methodist, including child institutions. 411 works · 6,335 citations · 71% open access · 9% clinical trials · 2% reviews.
Shares Future of Cancer Care Today (FCCT), Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT), Personalised neoantigen (mRNA) vaccines and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.
Shares Future of Cancer Care Today (FCCT) and the tag fcct-directory.